These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 631444)

  • 1. C-peptide in conditions other than diabetes mellitus.
    Horwitz DL; Rubenstein AH; Mako ME; Cruz A; Blix PM
    Diabetes; 1978; 27 Suppl 1():267-71. PubMed ID: 631444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of circulating C-peptide in diabetes mellitus and hypoglycemic disorders.
    Rubenstein AH; Kuzuya H; Horwitz DL
    Arch Intern Med; 1977 May; 137(5):625-32. PubMed ID: 193451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypoglycemia-induced inhibition of insulin secretion in metabolically healthy subjects, in diabetics and in patients with adrenalectomy].
    Krause U; Faisst G; Cordes U; Beyer J
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1391-3. PubMed ID: 611850
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypoglycemia factitia: Munchhausen syndrome in diabetes mellitus.
    Jermendy G
    J Diabetes Complications; 1996; 10(4):223-5. PubMed ID: 8835923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-peptide measurement: methods and clinical utility.
    Bonser AM; Garcia-Webb P
    Crit Rev Clin Lab Sci; 1984; 19(4):297-352. PubMed ID: 6373142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction.
    Polonsky K; Jaspan J; Pugh W; Cohen D; Schneider M; Schwartz T; Moossa AR; Tager H; Rubenstein AH
    J Clin Invest; 1983 Sep; 72(3):1114-23. PubMed ID: 6350363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human C-peptide immunoreactivity (CPR) in blood and urine - evaluation of a radioimmunoassay method and its clinical applications.
    Kuzuya T; Saito T; Yoshida S; Matsuda A
    Diabetologia; 1976 Oct; 12(5):511-8. PubMed ID: 976638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expanding clinical use of C-peptide radioimmunoassay.
    Rendell M
    Acta Diabetol Lat; 1983; 20(2):105-13. PubMed ID: 6410638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations.
    Polonsky KS; Rubenstein AH
    Diabetes; 1984 May; 33(5):486-94. PubMed ID: 6373457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylsalicylic acid augments insulin and C-peptide responses to arginine in diabetes mellitus.
    Giugliano D; Cacciapuoti F; Varricchio M
    Prostaglandins Med; 1979 Feb; 2(2):109-10. PubMed ID: 398985
    [No Abstract]   [Full Text] [Related]  

  • 11. The validity of C-peptide measurement in the diagnosis of factitious hypoglycemia.
    Dimitriadis G; Raptis S; Zoupas C; Schizas N
    Acta Diabetol Lat; 1980; 17(1):67-71. PubMed ID: 6998244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
    Montgomery TM; Nelson RW; Feldman EC; Robertson K; Polonsky KS
    J Vet Intern Med; 1996; 10(3):116-22. PubMed ID: 8743209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-peptide measurement and its clinical usefulness: a review.
    Bonser AM; Garcia-Webb P
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):200-6. PubMed ID: 7025733
    [No Abstract]   [Full Text] [Related]  

  • 14. Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies.
    Scarlett JA; Mako ME; Rubenstein AH; Blix PM; Goldman J; Horwitz DL; Tager H; Jaspan JB; Stjernholm MR; Olefsky JM
    N Engl J Med; 1977 Nov; 297(19):1029-32. PubMed ID: 198659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the inhibitory effect of insulin and hypoglycemia on insulin secretion in humans.
    Fruehwald-Schultes B; Kern W; Born J; Fehm HL; Peters A
    Metabolism; 2000 Jul; 49(7):950-3. PubMed ID: 10910009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [C-peptide: secretion and metabolism in different functional states and with abnormal B-cell function (author's transl)].
    Krause U; Cordes U; Beyer J
    Dtsch Med Wochenschr; 1977 May; 102(21):785-90. PubMed ID: 872737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical value of C-peptide assay (author's transl)].
    Vialettes B; Vague P
    Diabete Metab; 1980 Sep; 6(3):225-9. PubMed ID: 7002655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [C-peptide residual secretion makes difference on type 1 diabetes management?].
    Rodacki M; Milech A; Oliveira JE
    Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):322-33. PubMed ID: 18438543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of the secretion rate of insulin from the urinary excretion rate of C-peptide. Study in obese and diabetic subjects.
    Meistas MT; Rendell M; Margolis S; Kowarski AA
    Diabetes; 1982 May; 31(5 Pt 1):449-53. PubMed ID: 6759260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of improved glycemic control on C-peptide secretion in patients without residual B-cell function.
    Seigler DE; Reeves ML; Skyler JS
    Diabetes Care; 1982; 5(3):334-6. PubMed ID: 6756843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.